---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-104899"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:06:49.688548+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics adds Quimi and Walbert to board after Casdin resigns

## Summary
- Eli Casdin resigned as Class I director effective Oct 1, 2022, not due to any disagreement with the Company.
- Board expanded to 8 seats; appointed Daphne Quimi (CFO of Amicus Therapeutics) as Class I director.
- Appointed Timothy P. Walbert (CEO of Horizon Therapeutics) as Class II director.
- Quimi joins Audit and Nominating/Governance committees; Walbert joins Compensation Committee.
- Each received a non-qualified option for 39,744 shares at $9.89, vesting over 36 months.

## SEC filing metadata
- accession: 0001104659-22-104899
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/tm2227161d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-104899
- JSON: https://secwatch.observer/filing/0001104659-22-104899.json
- Plain text: https://secwatch.observer/filing/0001104659-22-104899.txt

## Key facts
- Executive change
  Eli Casdin resigned as Director at Century Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: Eli Casdin tendered his resignation as a member of the board of directors (the “ Board ”) of Century Therapeutics, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm
- Executive change
  Timothy P. Walbert was appointed as Director at Century Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: and (ii) Mr. Timothy P. Walbert to serve as a Class II director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm
- Executive change
  Daphne Quimi was appointed as Director at Century Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed (i) Ms. Daphne Quimi to serve as a Class I director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465922104899/0001104659-22-104899-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.